1. Home
  2. KALA vs FEDU Comparison

KALA vs FEDU Comparison

Compare KALA & FEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • FEDU
  • Stock Information
  • Founded
  • KALA 2009
  • FEDU 2007
  • Country
  • KALA United States
  • FEDU China
  • Employees
  • KALA N/A
  • FEDU N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • FEDU
  • Sector
  • KALA Health Care
  • FEDU
  • Exchange
  • KALA Nasdaq
  • FEDU NYSE
  • Market Cap
  • KALA 26.2M
  • FEDU 21.6M
  • IPO Year
  • KALA 2017
  • FEDU 2017
  • Fundamental
  • Price
  • KALA $8.40
  • FEDU $14.74
  • Analyst Decision
  • KALA Strong Buy
  • FEDU
  • Analyst Count
  • KALA 3
  • FEDU 0
  • Target Price
  • KALA $14.00
  • FEDU N/A
  • AVG Volume (30 Days)
  • KALA 204.0K
  • FEDU 2.7K
  • Earning Date
  • KALA 08-05-2025
  • FEDU 08-05-2025
  • Dividend Yield
  • KALA N/A
  • FEDU 16.29%
  • EPS Growth
  • KALA N/A
  • FEDU N/A
  • EPS
  • KALA N/A
  • FEDU 0.05
  • Revenue
  • KALA N/A
  • FEDU $34,475,202.00
  • Revenue This Year
  • KALA N/A
  • FEDU N/A
  • Revenue Next Year
  • KALA N/A
  • FEDU N/A
  • P/E Ratio
  • KALA N/A
  • FEDU $292.25
  • Revenue Growth
  • KALA N/A
  • FEDU 100.15
  • 52 Week Low
  • KALA $2.92
  • FEDU $3.69
  • 52 Week High
  • KALA $11.20
  • FEDU $22.70
  • Technical
  • Relative Strength Index (RSI)
  • KALA 74.24
  • FEDU 63.84
  • Support Level
  • KALA $5.35
  • FEDU $14.59
  • Resistance Level
  • KALA $8.49
  • FEDU $15.96
  • Average True Range (ATR)
  • KALA 0.79
  • FEDU 0.59
  • MACD
  • KALA 0.24
  • FEDU -0.13
  • Stochastic Oscillator
  • KALA 97.13
  • FEDU 58.46

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)

Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.

Share on Social Networks: